Advertisement

Correction to: Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells

  • Qun WangEmail author
  • Weijun Lu
  • Tao Yin
  • Li LuEmail author
Open Access
Correction

Correction to: J Exp Clin Cancer Res (2019) 38:240

https://doi.org/10.1186/s13046-019-1243-7

In the original publication of this article [1], there is a mistake in Fig. 7. The tags of TGF-beta and calycosin in Western blotting electrophoresis images are reversed.

The corrected Fig. 7 should be:

Fig. 7

a After HCT116 cells were treated with calycosin, TGF-β, or calycosin with TGF-β, western blot analysis was used to determine the protein levels of vimentin, Snail, and N-cadherin and the subcellular distribution of β-catenin protein. b After LoVo cells were treated with calycosin, TGF-β, or calycosin with TGF-β, western blot analysis was used to determine the protein levels of vimentin, Snail, and N-cadherin and the subcellular distribution of β-catenin proteins

Reference

  1. 1.
    Wang Q, et al. Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells. J Exp Clin Cancer Res. 2019;38:240 https://jeccr.biomedcentral.com/articles/10.1186/s13046-019-1243-7.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Department of Hepatopancreatobiliary SurgeryHubei Cancer HospitalWuhanPeople’s Republic of China
  2. 2.Department of Medical Oncology, Hubei Cancer Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanPeople’s Republic of China
  3. 3.Colorectal Cancer Clinical Research Center of WuhanWuhanPeople’s Republic of China
  4. 4.Colorectal Cancer Clinical Research Center of Hubei ProvinceWuhanPeople’s Republic of China
  5. 5.Department of Gastrointestinal SurgeryHubei Cancer HospitalWuhanPeople’s Republic of China

Personalised recommendations